Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 457,732 | 38,170 | 101,094 | -360,386 | -167,041 |
| Depreciation Amortization | 13,308 | 12,341 | 8,207 | 8,664 | 7,190 |
| Accounts receivable | 28,862 | -38,545 | -21,336 | -14,451 | -35,634 |
| Accounts payable and accrued liabilities | 3,012 | 6,194 | -32,542 | 29,938 | 9,565 |
| Other Working Capital | -60,864 | -62,169 | 71,146 | 58,704 | 32,458 |
| Other Operating Activity | -506,707 | 44,506 | 92,689 | 8,932 | -50,761 |
| Operating Cash Flow | $-64,657 | $497 | $219,258 | $-268,599 | $-204,223 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -613,793 | -79,405 | -285,029 | 316,440 | -434,612 |
| PPE Investments | -14,120 | -17,933 | -32,612 | -36,664 | -16,756 |
| Net Acquisitions | 608,503 | N/A | -2,990 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 324 | N/A |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -10,000 | 1,278 | 29,495 | 16,488 | 145,048 |
| Investing Cash Flow | $-29,410 | $-96,060 | $-291,136 | $296,588 | $-306,320 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,898 | 36,199 | 61,705 | 17,753 | N/A |
| Debt Repayment | -24,640 | -30,592 | N/A | -26,923 | N/A |
| Common Stock Issued | 1,578 | 790 | 5,094 | 174 | 717,319 |
| Common Stock Repurchased | N/A | -36,064 | -9,071 | -48,084 | -27,309 |
| Dividend Paid | N/A | -1,000 | -9,068 | -25,600 | -9,894 |
| Other Financing Activity | 0 | 0 | 0 | -83 | -30,088 |
| Financing Cash Flow | $7,836 | $-30,667 | $48,660 | $-82,763 | $650,028 |
| Exchange Rate Effect | 3,603 | -3,401 | -6,471 | -9,490 | 2,427 |
| Beginning Cash Position | 153,958 | 283,589 | 313,278 | 377,542 | 235,630 |
| End Cash Position | 71,330 | 153,958 | 283,589 | 313,278 | 377,542 |
| Net Cash Flow | $-82,628 | $-129,631 | $-29,689 | $-64,264 | $141,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,657 | 497 | 219,258 | -268,599 | -204,223 |
| Capital Expenditure | -14,148 | -17,933 | -32,612 | -36,664 | -16,756 |
| Free Cash Flow | -78,805 | -17,436 | 186,646 | -305,263 | -220,979 |